Vanda Pharmaceuticals Inc
NASDAQ:VNDA

Watchlist Manager
Vanda Pharmaceuticals Inc Logo
Vanda Pharmaceuticals Inc
NASDAQ:VNDA
Watchlist
Price: 6.23 USD -5.61% Market Closed
Market Cap: 368.2m USD

Wall Street
Price Targets

VNDA Price Targets Summary
Vanda Pharmaceuticals Inc

Wall Street analysts forecast VNDA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VNDA is 11.99 USD with a low forecast of 5.05 USD and a high forecast of 21 USD.

Lowest
Price Target
5.05 USD
19% Downside
Average
Price Target
11.99 USD
92% Upside
Highest
Price Target
21 USD
237% Upside
Vanda Pharmaceuticals Inc Competitors:
Price Targets
301207
Hualan Biological Bacterin Inc
3% Downside
CDNA
CareDx Inc
14% Upside
XOMA
XOMA Corp
186% Upside
688687
Beijing Kawin Technology Share-holding Co Ltd
91% Upside
BCAX
Bicara Therapeutics Inc
80% Upside
BIIB
Biogen Inc
4% Upside
688331
RemeGen Co Ltd
8% Upside
MDXG
MiMedx Group Inc
72% Upside

Revenue
Forecast

Revenue Estimate
Vanda Pharmaceuticals Inc

For the last 13 years the compound annual growth rate for Vanda Pharmaceuticals Inc's revenue is 15%. The projected CAGR for the next 3 years is 19%.

15%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Vanda Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

Net Income
Forecast

Net Income Estimate
Vanda Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VNDA's stock price target?
Price Target
11.99 USD

According to Wall Street analysts, the average 1-year price target for VNDA is 11.99 USD with a low forecast of 5.05 USD and a high forecast of 21 USD.

What is Vanda Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
19%

For the last 13 years the compound annual growth rate for Vanda Pharmaceuticals Inc's revenue is 15%. The projected CAGR for the next 3 years is 19%.

Back to Top